Effects of a 2‐Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity
Obesity · 2026-05 · 34 (5) · 1032-1044
DOI: 10.1002/oby.70189 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Obesity, online erschienen am 04.04.2026. Verfasst von Kara D Denstel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA. Hauptthemen laut MEDLINE: Quality of Life, Obesity, Weight Loss, Weight Reduction Programs. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NIMHD NIH HHS.
Abstract (Originalsprache)
Objective
This study examined (1) the association between weight loss and changes in health‐related quality of life (HRQoL) and (2) treatment response heterogeneity among patients in a weight loss intervention.
Methods
Eighteen primary care clinics were randomized to a 24‐month intensive lifestyle intervention or usual care. Generic HRQoL and weight‐related QoL were assessed at baseline and months 6, 12, and 24. Associations were analyzed using repeated‐measures linear multilevel models.
Results
The sample included 803 patients with obesity. Changes in generic HRQoL did not differ by race or sex, and weight‐related QoL did not differ by sex. However, Black patients experienced less improvement in weight‐related QoL compared to other races. There was a graded association between improvements in weight‐related QoL and greater weight loss between baseline and 24 months: 7.4 (95% CI: 5.1, 9.7) for those who lost < 5% of their initial body weight, 15.0 (11.4, 18.5) for 5% to < 10% weight loss, and 18.9 (15.4, 22.4) for ≥ 10% weight loss. Greater weight loss was also related to greater improvements in most generic HRQoL domains.
Conclusions
Weight loss was associated with improvements in HRQoL, and race differences were identified in changes in weight‐related QoL, highlighting the need for precision medicine approaches to weight loss. Trial Registration ClinicalTrials.gov identifier NCT02561221
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
- Department of Medicine and Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
- Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, New Orleans, Louisiana, USA.
- Ochsner Clinical School-University of Queensland School of Medicine, New Orleans, Louisiana, USA.
- Ochsner Xavier Institute for Health Equity and Research, New Orleans, Louisiana, USA.
ORCID-Profile: John W Apolzan, Peter T Katzmarzyk
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIMHD NIH HHS
- Patient-Centered Outcomes Research Institute
- National Institute of General Medical Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Denstel, K. D., Mire, E. F., Martin, C. K., Apolzan, J. W., Arnold, C. L., Davis, T. C., Lavie, C. J., Newton, R. L., Zhang, D., Price-Haywood, E. G., Katzmarzyk, P. T., & PROPEL Research Group (2026). Effects of a 2‐Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity. Obesity, 34(5), 1032-1044. https://doi.org/10.1002/oby.70189
Vancouver
Denstel KD, Mire EF, Martin CK, Apolzan JW, Arnold CL, Davis TC, et al. Effects of a 2‐Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity. Obesity. 2026;34(5):1032-1044. doi:10.1002/oby.70189
BibTeX
@article{Denstel2026,
author = {Denstel, Kara D and Mire, Emily F and Martin, Corby K and Apolzan, John W and Arnold, Connie L and Davis, Terry C and Lavie, Carl J and Newton, Robert L and Zhang, Dachuan and Price-Haywood, Eboni G and Katzmarzyk, Peter T and PROPEL Research Group, PROPEL Research Group},
title = {Effects of a 2‐Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity},
journal = {Obesity},
year = {2026},
volume = {34},
number = {5},
pages = {1032--1044},
doi = {10.1002/oby.70189}
}
EUVIMED